Contact Us

Prempro
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Did a heart attack occur within one year of taking Premphase or Prempro?

Were any of the following problems experienced during or after taking HRT medication?









If you suffered any of the above conditions, what was your age when diagnosed?

What was the date you were diagnosed with TTP?

Please describe diagnosis:

Please describe history of HRT drug prescriptions (please provide date and drug used in chronological order):

If diagnosed with breast cancer, please indicate details of diagnosis:



Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?

If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?

If you have been screened for breast cancer, please describe results:

Please describe history of blood clots and/or strokes:

Did you ever take Provera?

If yes, did you take Provera while taking Premphase or Premarin?

Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


FDA Unveils Hormone Guidelines

Government campaign aims to educate women about HRT

Sep 9, 2003 | AP

Women who choose hormone therapy to treat symptoms of menopause should use the lowest dose for the shortest amount of time. That’s the theme of a new government campaign that aims to help women confused by news about the risks of long-term hormone use even as hormones remain a mainstay for treating hot flashes.

A YEAR AGO, a major study concluded that long-term use of the hormones estrogen and progestin is more dangerous than once thought. The pills significantly increased a woman’s risk of a heart attack or stroke beginning in the first year of use and increased the risk of breast cancer after four years of use.

But hormone therapy does have some benefits. It’s considered the most effective treatment for hot flashes, night sweats and vaginal dryness. It’s also one option to prevent bone-thinning osteoporosis.

So who should try hormones, at what dose and for how long? Congress told the Food and Drug Administration to design consumer-friendly education materials to help women figure that out.

Tuesday, the FDA unveiled a Web site, http://www.fda.gov/womens/menopause with hormone information, including a pocket guide to bring to the doctor’s office when discussing options. It explains how to weigh the risks and benefits of both the estrogen-progestin combination and estrogen alone, an option only for women who have had hysterectomies.

Women can print out the information; also, FDA has partnered with several women’s health groups to distribute it.

“Women who are armed with the appropriate key facts can take the right steps to make the highly personal decision about whether menopausal hormone therapy is the right choice for them,†said FDA Administrator Mark McClellan.


Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo